Journal of the Korean Ophthalmological Society 2002;43(1):204-212.
Published online January 1, 2002.
The inhibitory Effects of Mitomycin-C on the Development of Proliferative Vitreoretinopathy.
Kwang Soo Kim, Se Yup Lee, Jong Hyun Kim
Department of Ophthalmology, Keimyung University School of Medicine, Korea. kimks@dsmc.or.kr
증식유리체망막병증의 발생에 있어서 Mitomycin-C의 억제효과
김광수 ( Kwang Soo Kim ) , 이세엽 ( Se Yup Lee ) , 김종현 ( Jong Hyun Kim )
Abstract
PURPOSE
To investigate the inhibitory effect of MMC on experimental PVR. METHODS: The cultured rabbit fibroblasts were pretreated with 3microgram/L and 300microgram/L concentration of MMC for 30 minutes. MMC-treated and -untreated fibroblasts were injected into vitreous cavity of pigmented rabbits and the development of PVR was compared each other. The retinal toxicity of MMC was evaluated histopathologically after 30 minutes-intravitreal infusion with the same concentration of MMC. RESULTS: On the final examination 8 weeks after intravitreal injection, the rate of PVR was 90%, 67%, and 20% in control group without MMC treatment, 3.0 microgram/L MMC-treated group, and 300 microgram/L MMC-treated group, respectively. The severity of PVR was milder in treatment groups than in non-treatment group in general, and the rate of PVR between control group and 300 microgram/L MMC-treated group was statistically significant (P<0.01). At 1 and 4 weeks of histopathologic study using the light and electromicroscopy to evaluate the retinal toxicity to MMC, the retina and retinal pigment epithelium showed similar findings in MMC-treated groups compared to non-MMC-treated control group. CONCLUSIONS: These results show that pharmacologic therapy with MMC may be useful in the prevention of development and recurrence of PVR in the management of complex retinal detachment.
Key Words: Fibroblast;Mitomycin-C;Proliferative Vitreoretinopathy


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next